Delivery Order SPE2DB22D9316-SPE2DB25FYN08

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,054.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Jakafi 10 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs of military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $35,321.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the medication Jakafi 15 mg tablets, with a completion date of August 15, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
The U.S. government awarded a delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the provision of the pharmaceutical product Jakafi 10 mg tablet. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, provides for the delivery of Jakafi 15 mg tablets to support the medical supply needs of U.S. government agencies, particularly the Department of Defense. This Delivery Order is issued under DMS Pharmaceutical Group's...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 60 units of the prescription drug Jakafi 15 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $499,999,999 between DMS Pharmaceutical Group and the DLA, which covers a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $47,362.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of October 8, 2024 and provides for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,300.73 contract is to provide the DLA with 4,556,044,091 units of the drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue firm fixed-price orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for the supply of JAKAFI 10 MG TABLET 60S and has an ultimate completion date of October 29, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide...
This federal contract award from the Defense Logistics Agency (DLA) was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,300.73 firm fixed-price delivery order is for the supply of Jakafi 10 mg tablets, with a completion date of November 18, 2021. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This federal contract award, valued at $11,840.66, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's Medical Supply Chain program, with a firm fixed-price pricing type and an ultimate completion date of May 9, 2024. The award is for the delivery of a specific pharmaceutical product, Jakafi 10 mg tablets, to support the medical...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYN08
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Jakafi 10 mg tablets, a specialty pharmaceutical product, with a performance period through January 14, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical items.

Generated 4/14/25, 10:28 AM